Editorial Concerning "The Association Between Diabetes Medication Use and Tumour Characteristics at Diagnosis in Patients with Urothelial Carcinoma: A Retrospective Registry-Based Study"
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Sun J, Zhao L, Yang Y, Ma X, Wang Y, Xiang Y
. Obesity and risk of bladder cancer: a dose-response meta-analysis of 15 cohort studies. PLoS One. 2015; 10(3):e0119313.
PMC: 4372289.
DOI: 10.1371/journal.pone.0119313.
View
2.
Zhu Z, Wang X, Shen Z, Lu Y, Zhong S, Xu C
. Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies. BMC Cancer. 2013; 13:310.
PMC: 3699355.
DOI: 10.1186/1471-2407-13-310.
View
3.
Tuccori M, Filion K, Yin H, Yu O, Platt R, Azoulay L
. Pioglitazone use and risk of bladder cancer: population based cohort study. BMJ. 2016; 352:i1541.
PMC: 4816602.
DOI: 10.1136/bmj.i1541.
View
4.
Lu Y, Tao J
. Diabetes Mellitus and Obesity as Risk Factors for Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2021; 12:699732.
PMC: 8529220.
DOI: 10.3389/fendo.2021.699732.
View
5.
Yao X, Liu H, Xu H
. The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis. Biomed Res Int. 2021; 2021:5311828.
PMC: 8519697.
DOI: 10.1155/2021/5311828.
View